Korea: A recent randomized, double-blind, placebo-controlled study has revealed promising results for adding dapagliflozin to ...

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

New research found that Dapagliflozin reduces the relative and absolute risk of death and heart failure-related ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

In patients older than 40 years, the type 2 diabetes drug class showed increased benefits over DPP-4 inhibitors at reducing ...

The doctor may suggest some other medicine which could be more effective in treating your diabetes. For some people, taking metformin alone can effectively lower blood sugar levels. But, evidence ...

Diabetes drugs that cost £1 a day and are already available on the NHS could prevent the onset of dementia, a BMJ study has ...

The "Type 2 Diabetes in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ResearchAndMarkets.com's offering. This report provides a ...

Global data from WHO demonstrate a significant disproportionality for semaglutide and suicidal ideation compared with all medications.